Breckenridge Pharmaceutical, Inc. Announces Final Approval of its ANDA Entecavir tablets (Baraclude(R))

BOCA RATON, Fla., March 27, 2018 -- (Healthcare Sales & Marketing Network) -- Breckenridge Pharmaceutical, Inc. announced today that the U.S. Food and Drug Administration has granted final approval for its Abbreviated New Drug Application for Entecavir ta... Biopharmaceuticals, Generics, FDA Breckenridge Pharmaceutical, Entecavir, Baraclude, hepatitis B virus
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news